Fig. 1 · Structure

Documents & Downloads

VTP50469 mesylate

Epigenetic Reader Domain Inhibitor

VTP50469 mesylate is a selective inhibitor of the Menin-MLL1 interaction, primarily targeting MLL-rearranged and NPM1c+ leukemias. This compound effectively induces cell death in cell lines harboring MLL rearrangements and NPM1c+ mutations by displacing Menin from protein complexes and inhibiting MLL's chromatin occupancy at specific gene loci. The resultant alterations in gene expression lead to enhanced differentiation and apoptosis. In preclinical studies using patient-derived xenograft models, VTP50469 has demonstrated substantial reductions in leukemia burden and prolonged disease-free survival in treated subjects.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 2169919-27-9
Applications Epigenetic Reader Domain Inhibitor
Formula C34H55FN6O10S3
Molecular Weight 823.03
Synonyms SNDX-50469 mesylate
SMILES
CS(=O)(O)=O.CC(C)N(C(C)C)C(C(C=C(C=C1)F)=C1OC2=CN=CN=C2N(C3)CC3(CC4)CCN4C[C@@H]5CC[C@H](CC5)NS(C)(=O)=O)=O.CS(=O)(O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...